Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Daiichi Sankyo Ltd ADR (DSNKY)

Daiichi Sankyo Ltd ADR (DSNKY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
300,000 New Cases: The Role of Biotech in Addressing Rising Breast Cancer Rates BayStreet.ca - Fri Dec 1, 2023

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 76.41 (+0.70%)
ONCY : 1.1200 (+0.90%)
ONC.TO : 1.54 (+0.65%)
DSNKY : 33.5650 (+0.58%)
GILD : 65.51 (+0.48%)
ARAY : 2.17 (+1.88%)
Investing in Hope: Biotech Innovations Targeting Increased Breast Cancer Rates in 2023 BayStreet.ca - Thu Nov 23, 2023

USA News Group – Breast cancer rates are increasing this year, with nearly 300,000 new cases of invasive breast cancer diagnosed in women and 2,800 new cases in men. While breast cancer survival rates...

AZN : 76.41 (+0.70%)
ONCY : 1.1200 (+0.90%)
ONC.TO : 1.54 (+0.65%)
DSNKY : 33.5650 (+0.58%)
GILD : 65.51 (+0.48%)
ARAY : 2.17 (+1.88%)
Merck Just Made a Big Move -- but Will It Be Enough for Investors Right Now? Motley Fool - Tue Oct 31, 2023

In due time, its new partnership with Daiichi Sankyo could be massive.

MRK : 128.80 (-0.33%)
DSNKY : 33.5650 (+0.58%)
Is Gilead Sciences a Good Stock to Buy Now? Motley Fool - Mon Feb 6, 2023

Gilead Sciences' breast cancer drug, Trodelvy, just took a big step forward.

PFE : 27.18 (+6.09%)
DSNKY : 33.5650 (+0.58%)
GILD : 65.51 (+0.48%)
AZN : 76.41 (+0.70%)

Barchart Exclusives

Down 12% from Highs, Should You Buy the Dip in This Dividend Aristocrat? Barchart - 42 minutes ago
This prominent paint industry player has been raising dividends for more than four decades. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot